NCT05439369

Brief Summary

NPs can be used To detect subset of asymptomatic with subtle LV dysfunction for further evaluation and earlier referral for intervention and its correlation with echocardiographic finding.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 17, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 30, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

August 1, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
Last Updated

June 30, 2022

Status Verified

June 1, 2022

Enrollment Period

5 months

First QC Date

June 17, 2022

Last Update Submit

June 29, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • early detection of subclinical LV dysfunction.

    early detection of subclinical LV dysfunction.

    1 year

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

the study will include consecutive eligible patients recruited in assiut university hospital

You may qualify if:

  • All patients echocardiographically diagnosed with significant valve lesions. Rheumatic Heart disease with significant but asymptomatic valvular Heart Disease especially (Mitral valve disease )(MS and MR) Gender: male \& female

You may not qualify if:

  • Cases with increased level of BNP as in :
  • Renal impairment Advanced age and obesity Atrial fibrillation and acute coronary syndromes Prior lung diseases and acute illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University ,faculty of medicine

Asyut, Egypt

RECRUITING

MeSH Terms

Conditions

Gastroesophageal Reflux

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Mohamed Aly Abdelhafez, Lecturer

    Assiut University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Muhammad KE thabet, resident

CONTACT

Amr Ahmed Aly Yousif, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Doctor

Study Record Dates

First Submitted

June 17, 2022

First Posted

June 30, 2022

Study Start

August 1, 2022

Primary Completion

January 1, 2023

Study Completion

January 1, 2023

Last Updated

June 30, 2022

Record last verified: 2022-06

Locations